Filter By Industry
Filter By Tag

Newsroom

DelveInsight Press releases

1 - 10 of 145 Press Releases

Jun 05, 2018
DelveInsight's "Alopecia - Market Insights, Epidemiology and Market Forecast – 2027" report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology.

Apr 23, 2018
"AMPA Receptor Antagonist -Pipeline Insight" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across AMPA Receptor Antagonist development.

Apr 18, 2018
"Anaplastic Thyroid Cancer - Pipeline Insight, 2018" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across Anaplastic Thyroid Cancer.

Apr 16, 2018
"Angina (Angina Pectoris) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018" report by DelveInsight offers comprehensive insights on marketed and Phase III products for Angina (Angina Pectoris).

Apr 11, 2018
"Acute Lung Injury" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across Acute Lung Injury.

Apr 10, 2018
"Human papillomavirus (HPV) Associated Cancer - Pipeline Insight, 2018" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across Human papillomavirus (HPV) Associated Cancer.

Apr 06, 2018
"Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Insight, 2018" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across Acute Renal Failure (ARF) (Acute Kidney Injury).

Mar 26, 2018
"1,3-Beta-Glucan Synthase Inhibitor -Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 1,3-Beta-Glucan Synthase Inhibitor development.

Oct 06, 2017
About Atopic dermatitis (AD) is a chronic inflammatory skin disease and is characterized by widespread skin lesions, which manifest as red, itchy, swollen, cracked, weeping lesions with crusting/scaling, intractable pruritus (most common and persistent...

Sep 14, 2017
The Hepatitis C arena currently has around 23 marketed drugs due to the increasing number of patients globally as per the latest report of DelveInsight.


Page: 1 2 3 4 5 Next
DelveInsight RSS Feed